Vnitr Lek 2005, 51(2):226-230

Congenital adrenal hyperplasia, defect of 17α-hydroxylase as a rare cause of hypertension and hypocalaemia

V. Olšovská1,*, J. Šulcová2, A. Hondlová1, H. Šiprová1
1 II. interní klinika Lékařské fakulty MU a FN u sv. Anny, Brno, přednosta doc. MUDr. Miroslav Souček, CSc.
2 Oddělení steroidních hormonů Endokrinologického ústavu, Praha, ředitel doc. MUDr. Vojtěch Hainer, CSc.

Authors describe infrequently occurring case of congenital adrenal hyperplasia, partial defect of 17α-hydroxylase in female patient with hypertension, hypocalaemia, menstrual cycle disorders and sterility. Diagnosis was established on the basis of native examination of steroid spectrum together with both stimulation and suppression tests and CT examination. After the treatment with dexamethason was established, the blood pressure and electrolyte levels reached the correction. This report supports the importance of the whole steroid spectrum examination in the patients with this symptomatology in order to eliminate rare causes of endocrine hypertension.

Keywords: congenital adrenal hyperplasia; endocrine hypertension; hypocalaemia; defect of 17α-hydroxylase

Received: March 11, 2004; Accepted: April 14, 2004; Published: February 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Olšovská V, Šulcová J, Hondlová A, Šiprová H. Congenital adrenal hyperplasia, defect of 17α-hydroxylase as a rare cause of hypertension and hypocalaemia. Vnitr Lek. 2005;51(2):226-230.
Download citation

References

  1. Hampl R, Stárka L. Současné možnosti steroidní laboratorní diagnostiky. DMEV 1999; 4: 206-211.
  2. Šulcová J, Stárka L. Adrenální enzymopatie s pozdním nástupem. In: Stárka L et al. Aktuální endokrinologie. Praha: Maxdorf 1999: 540-562.
  3. Procházková V, Lebl J et al. Klinická diagnostika pacientů s kongenitální adrenální hyperplazií. Česko-slovenská pediatrie 1999; 10: 544-547.
  4. Costa-Santos M, Kater CE et al. Two prevalent CYP17 mutations and genotype-phenotype correlations in 24 Brazilian patients with 17-hydroxylase deficiency. Hum Genet 2004; 89: 95-96. Go to original source...
  5. Van Den Akker EL, Koper JW et al. Differential inhibition of 17-hydroxylase an 17, 20-lyase activities by three movel missense CYP 17 mutations identified in patients with P450c17 deficiency. J Clin Endocrinol Metab 2002; 87. 5714-5719. Go to original source... Go to PubMed...
  6. Biglieri EG, Herron MA et al. 17-hydroxylation deficiency in man. J Clin Invest 1966; 45: 1946-1954. Go to original source... Go to PubMed...
  7. Imai T, Yanase T et al. Canadian Mennonites and individuals residing in the Friesland region of The Netherlands share the same molecular basis of 17-hydroxylase deficiency. Hum Genet 1992; 89: 95-96. Go to original source... Go to PubMed...
  8. Costa-Santos M., Kater, CE et al. Two intronic mutations cause 17-hydroxylase deficiency by disrupting splice acceptor sites: direct demonstration of abberant splicing and absent enzyme activity by expression of the entire CYP17 gene in HEK-293 cells. J Clin Metab 2004, 89, 43-48. Go to original source... Go to PubMed...
  9. Kater CE, Biglieri EG. Disorders of steroid 17-hydroxylase deficiency. Endocrin Metab Clin North Am 1994; 23: 341-357. Go to original source...
  10. Grumbach MM, Hughes IA et al. Disorders of sex differentiation. In: Larsen PR, Kronnenberg HM et al. Wiliams textbook of endocrinology. 10th ed. Philadelphia: WB Saunders 2003; 842-1002.
  11. Yanase T, Simpson ER et al. 17-hydroxylase/17,20 lyase deficiency: from clinical investigation to molecular definition. Endocrin Rev 1991; 12: 91-108. Go to original source... Go to PubMed...
  12. Mendonca BB, Inacio M et al. Male pseudohermafroditism due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency. Diagnosis, psychological evaluation and management. Medicine 2000; 79: 299-309. Go to original source... Go to PubMed...
  13. Rabinovici J, Blankstein J et al. In vitro fertilization and primary embryonic cleabage beta estradiol, are possible in 17-hydroxylase deficiency despite extremely intrafollicular 17-beta estradiol. J Clin Metab 1989; 68: 693-697. Go to original source... Go to PubMed...
  14. Votava F, Kračmar P et al. Novorozenecký screening kongenitální adrenální hyperplazie. Čes Slov pediatrie 2002; 12: 690-696.
  15. Lisá L. Nové poznatky o léčbě vrozené adrenální hyperplazie. Forum medicinae 2000; 2: 52-57.
  16. Ferrari P, Bianchetti M. Juvenile hypertension, the role of genetically altered steroid metabolism. Hormone research 2001; 5: 213-223. Go to original source... Go to PubMed...
  17. Widimský J. Hypertenze. Praha: Triton 2002: 368-370.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.